Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis
| Autor: | Piulats, J.M., Watkins, C., Costa-García, M., del Carpio, L., Piperno-Neumann, S., Rutkowski, P., Hassel, J.C., Espinosa, E., de la Cruz-Merino, L., Ochsenreither, S., Shoushtari, A.N., Orloff, M., Salama, A.K.S., Goodall, H.M., Baurain, J.-F., Nathan, P. |
|---|---|
| Zdroj: | In Annals of Oncology March 2024 35(3):317-326 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|